Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Deloitte
Boehringer Ingelheim
Fish and Richardson
Federal Trade Commission
McKinsey
Express Scripts
Chubb
UBS
Fuji

Generated: February 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040023

« Back to Dashboard

NDA 040023 describes ADRUCIL, which is a drug marketed by Pharmacia And Upjohn and Teva Parenteral and is included in four NDAs. Additional details are available on the ADRUCIL profile page.

The generic ingredient in ADRUCIL is fluorouracil. There are fifteen drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the fluorouracil profile page.
Summary for 040023
Tradename:ADRUCIL
Applicant:Teva Parenteral
Ingredient:fluorouracil
Patents:0
Therapeutic Class:Dermatological Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 040023

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength50MG/ML
Approval Date:Oct 18, 1991TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
McKesson
Healthtrust
Chubb
Baxter
Covington
Boehringer Ingelheim
Daiichi Sankyo
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot